Skip to content

Comparing three ways of using parecoxib for pain relief after total knee arthroplasty

Analgesic effect of intraosseous parecoxib sodium injection during total knee arthroplasty: a single-center, three-arm, randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10410133
Enrollment
171
Registered
2026-05-13
Start date
2026-05-25
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with knee osteoarthritis who require total knee arthroplasty Musculoskeletal Diseases

Interventions

This study aims to compare the analgesic effects of three different administration routes of parecoxib sodium during total knee arthroplasty (TKA). Except for the specific routes described below, all

Sponsors

Luoyang Orthopedic-Traumatological Hospital of Henan Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 50–75 years with a primary diagnosis of knee osteoarthritis 2. Patients scheduled for primary, elective, unilateral total knee arthroplasty without clear contraindications to surgery 3. American Society of Anesthesiologists (ASA) physical status classification I–III 4. Willing to participate in the study and able to provide written informed consent

Exclusion criteria

Exclusion criteria: 1. Body mass index (BMI) >35 kg/m² or body weight 90 minutes), including: prior ipsilateral knee infection, history of complex fracture, previous periarticular osteotomy, massive periarticular bone defect, functional knee stiffness (preoperative maximum range of motion 20°, valgus >15°, or flexion >20°) 6. Participation in another clinical trial within the past 6 months 7. Any surgical procedure within the past 3 months 8. Presence of cognitive impairment or psychiatric disorder that prevents compliance with study assessments

Countries

China

Contacts

Public ContactXiaoya Liu
743229210@qq.com+86 (0)17836931893

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 30, 2026